Literature DB >> 204769

Position sensitivity of de-efferented muscle spindles in experimental acrylamide neuropathy.

H E Lowndes, T Baker, E S Cho, B S Jortner.   

Abstract

An experimental neuropathy was induced in cats by injections of acrylamide (7.5, 15 or 30 mg/kg/day) for 2 to 10 days. The responses of primary and secondary endings of soleus muscle spindles to stretch were evaluated and correlated with the appearance of ataxia and incoordinated motor movements. Animals that received 15 or 30 mg/kg/day became ataxic and demonstrated poor motor coordination on the 7th or 4th day, respectively. At these times, both primary and secondary endings of muscle spindles had elevated thresholds and diminished discharge frequencies. Continued acrylamide administration resulted in exacerbation of the clinical symptoms and further attenuation of spindle responses. The discontinuation of acrylamide was followed by slow recovery. Only those cats which received a total dose of 75 mg/kg or less remained asymptomatic and had normal spindle function. The coincidence of onset of motor coordination deficits and spindle dysfunction, coupled with a lack of demonstrable motor defect at the same time, suggests that the initial clinical features of acrylamide neuropathy may be partly the consequence of impaired spindle function.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 204769

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  The axon reaction in spinal ganglion neurons of acrylamide-treated rats.

Authors:  H B Jones; J B Cavanagh
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

2.  Hepatic UDP-glucuronyltransferase activity in acrylamide neuropathy.

Authors:  R D Howland; H E Lowndes
Journal:  Experientia       Date:  1979-02-15

3.  Abnormalities of oesophageal mechanoreceptors in canine acrylamide neuropathy.

Authors:  P M Satchell; J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

4.  Peripheral nerve phospholipids in acrylamide neuropathy.

Authors:  R D Howland; H E Lowndes
Journal:  Arch Toxicol       Date:  1984-09       Impact factor: 5.153

5.  Neurotoxicology of vincristine in the cat. Electrophysiological studies.

Authors:  B D Goldstein; H E Lowndes; E Cho
Journal:  Arch Toxicol       Date:  1981-11       Impact factor: 5.153

Review 6.  Molecular mechanisms of the conjugated alpha,beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases.

Authors:  Richard M LoPachin; David S Barber; Terrence Gavin
Journal:  Toxicol Sci       Date:  2007-12-13       Impact factor: 4.849

7.  Alterations in nerve and muscle compound action potentials after acute acrylamide administration.

Authors:  R J Anderson
Journal:  Environ Health Perspect       Date:  1982-04       Impact factor: 9.031

8.  Nrf2 Activation Attenuates Acrylamide-Induced Neuropathy in Mice.

Authors:  Chand Basha Davuljigari; Frederick Adams Ekuban; Cai Zong; Alzahraa A M Fergany; Kota Morikawa; Gaku Ichihara
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.